Cormorant Asset Management, LP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 122 filers reported holding REATA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$10,061,000
-57.7%
100,000
-40.5%
0.41%
-49.4%
Q2 2021$23,798,000
-40.3%
168,150
-58.0%
0.81%
-9.0%
Q1 2021$39,880,000
-35.5%
400,000
-20.0%
0.89%
-39.6%
Q4 2020$61,810,000
+41.0%
500,000
+11.1%
1.47%
-12.8%
Q3 2020$43,839,000
-29.8%
450,000
+12.5%
1.69%
-29.2%
Q2 2020$62,408,000
-41.4%
400,000
-45.7%
2.38%
-51.9%
Q1 2020$106,408,000
-51.2%
737,206
-30.9%
4.94%
-43.2%
Q4 2019$218,005,000
+231.2%
1,066,400
+30.1%
8.70%
+117.1%
Q3 2019$65,819,000
-13.5%
819,769
+1.7%
4.01%
-8.3%
Q2 2019$76,060,000
+44.7%
806,150
+31.1%
4.37%
+23.0%
Q1 2019$52,564,000
+39.0%
615,000
-8.8%
3.55%
+15.7%
Q4 2018$37,825,000
-29.9%
674,251
+2.2%
3.07%
-12.4%
Q3 2018$53,962,000
+242.9%
660,000
+46.7%
3.51%
+201.0%
Q2 2018$15,737,000
+70.5%
450,0000.0%1.16%
+69.3%
Q1 2018$9,230,000
+63.0%
450,000
+125.0%
0.69%
+16.0%
Q4 2017$5,664,000
-53.1%
200,000
-48.5%
0.59%
-72.2%
Q3 2017$12,085,000388,5742.13%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
CPMG Inc 3,063,567$298,453,00049.63%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 150,000$14,613,00019.62%
Corriente Advisors, LLC 300,000$29,226,00014.82%
Prosight Management, LP 114,554$11,160,0005.31%
MADDEN SECURITIES Corp 43,927$4,279,0003.18%
LBJ Family Wealth Advisors, Ltd. 30,368$2,958,0002.24%
Biondo Investment Advisors, LLC 99,652$9,708,0002.10%
Cormorant Asset Management, LP 450,000$43,839,0001.69%
Duquesne Family Office 543,901$52,987,0001.54%
AWH Capital, L.P. 9,500$925,0001.30%
View complete list of REATA PHARMACEUTICALS INC shareholders